SEC Form 4 · accession 0001179110-17-014722
YIELD10 BIOSCIENCE, INC. · YTEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony J Sinskey
Director
Period of report
Nov 28, 2017
Accepted (ET)
Nov 30, 2017 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001121702
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $2.34 | Nov 28, 2017 | A | 6,660 | A | Nov 28, 2017 | Nov 28, 2027 | Common Stock | 6,660 | 6,660 | D |
Explanation of responses
- F1These options were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the third quarter of 2017.
- F2All share numbers reported reflect the 1-for-10 reverse stock split effected on May 30, 2017.